APA (7th ed.) Citation

Vasudevan, A., Con, D., De Cruz, P., Sparrow, M. P., Friedman, A. B., Garg, M., . . . van Langenberg, D. R. (2024). Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study). Alimentary Pharmacology & Therapeutics, 59(4), 504. https://doi.org/10.1111/apt.17831

Chicago Style (17th ed.) Citation

Vasudevan, Abhinav, Danny Con, Peter De Cruz, Miles P. Sparrow, Antony B. Friedman, Mayur Garg, Soleiman Kashkooli, Peter R. Gibson, and Daniel R. van Langenberg. "Clinical Trial: Combination Allopurinol‐thiopurine Versus Standard Thiopurine in Patients with IBD Escalating to Immunomodulators (the DECIDER Study)." Alimentary Pharmacology & Therapeutics 59, no. 4 (2024): 504. https://doi.org/10.1111/apt.17831.

MLA (9th ed.) Citation

Vasudevan, Abhinav, et al. "Clinical Trial: Combination Allopurinol‐thiopurine Versus Standard Thiopurine in Patients with IBD Escalating to Immunomodulators (the DECIDER Study)." Alimentary Pharmacology & Therapeutics, vol. 59, no. 4, 2024, p. 504, https://doi.org/10.1111/apt.17831.